<DOC>
	<DOCNO>NCT00861536</DOCNO>
	<brief_summary>An open , multicenter , randomise , parallel group pilot study investigate two different polyclonal rabbit immunoglobulin preparation safety efficacy : A comparison ATG-Fresenius S Thymoglobulin prophylaxis immunological high risk patient follow renal transplantation . This non-inferiority trial shall demonstrate ATG-Fresenius S efficacious Thymoglobulin good tolerance few side effect .</brief_summary>
	<brief_title>Comparison ATG Thymoglobuline Renal Transplantation</brief_title>
	<detailed_description />
	<criteria>1 . Recipients , least 18 year old high immunological risk define : The presence least one donorspecific antibody ( class I and/or II ) detect specified flowtechnology ( FlowPRA single antigen bead ) , For class I threshold detection current CDC Tcell/ Bcell crossmatch For class II threshold detection current CDC Bcell crossmatch . 2 . Patient receive renal allograft . 3 . Female patient child bear age agree maintain effective birth control practice study . 4 . Patient fully inform give write independent person witness oral informed consent . 1 . Patient pregnant breastfeeding . 2 . Patient low immunological risk constellation , define receive kidney HLAidentical relate live donor . 3 . Patient donor positive Tcell crossmatch . 4 . Patient donor ABO incompatible . 5 . Patient combine transplantation . 6 . Age donor &gt; 75 year . 7 . Cold ischemia time &gt; 40 hour . 8 . Patient leucopenia , define transplantation le 3000/mm3 leukocyte . 9 . Patient thrombocytopenia , define transplantation le 75000/mm3 thrombocyte . 10 . Patient allergic intolerant ATGFresenius S , Thymoglobulin , steroid , Tacrolimus MMF . 11 . EBV risk constellation ( recipient EBV negative donor EBV positive ) . 12 . Patient donor know HIV positive . 13 . Patient liver disease , define continuously ASAT ( SGOT ) and/or ALAT ( SGPT ) level great 3fold upper value normal range investigational site past 28 day . 14 . Patient malignancy history malignancy &lt; 2 year , except non metastatic basal squamous cell carcinoma skin treat successfully . 15 . Patient uncontrolled concomitant infection and/or severe diarrhea , vomit , active peptic ulcer . 16 . Patient unlikely comply visit schedule protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>risk factor</keyword>
	<keyword>immunology</keyword>
</DOC>